Nant will use Illumina's HiSeq and NovaSeq platforms for sequencing. The primary purpose of this sequencing is to perform bioinformatic prediction of neoepitopes. However, clinically actionable gene variants may be discovered as a result of exome sequencing. Refer to section 5.1.3 .